Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia®) Activity Using Reagent-/Platform-Specific Conversion Factors.
Journal: Hamostaseologie
Published: August 29, 2025
The Indian Experience With Nonacog Beta Pegol for the Treatment of Hemophilia B in Children and Adolescents: A Safety and Efficacy Evaluation.
Journal: Cureus
Published: April 28, 2025
An Observational Study of Glycopegylated Extended Half-Life Factor Prophylaxis in Hemophilia A and B in a Tertiary Care Center in India.
Journal: Cureus
Published: February 25, 2025
The efficacy, safety, and pharmacokinetics of N8-GP in previously treated Chinese patients with haemophilia A: results from the phase 3b pathfinder10 study.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: September 13, 2024
Pegozafermin Is a Potential Master Therapeutic Regulator in Metabolic Disorders: A Review.
Journal: Cardiology in review
Published: October 27, 2023
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: August 14, 2023
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis.
Journal: Alimentary pharmacology & therapeutics
Published: July 13, 2023
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Journal: The New England journal of medicine
Published: June 25, 2023
Population Pharmacokinetics and Pharmacodynamics of Pegozafermin in Patients with Nonalcoholic Steatohepatitis.
Journal: Clinical pharmacology and therapeutics
Published: March 26, 2023
The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 14, 2023
Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 10, 2023
High variability in Factor IX one-stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system.
Journal: International journal of laboratory hematology
Published: January 30, 2023
Last Updated: 10/31/2025